Chandrayaan-1 will be taken over by Peenya in Bangalore, for keeping an eye on its operations, after the launch at Sriharikota. 

For the next two years, the main centre to tracking and controlling Chandrayaan, would be the ISRO Telemetry, Tracking and Command Network (Istrac) at Peenya, where hectic activities have already begun. 

On Tuesday, a System Center Virtual Machine Manager 2008 was launched by Microsoft. Through the launch of this Virtual Machine Manager, Microsoft added another key component to its virtualization arsenal. 

All important virtualization management pieces of Microsoft's strategy can be handled by Virtual Machine Manager 2008, and it has been learnt that Microsoft has spent much of 2008 deciding as to how the software could manage both Hyper-V and VMware's ESX hypervisor, as well as physical servers, through a single interface. 

It might be quite interesting and surprising to know, but India’s space program actually commenced at a church located in Thumba, a small village known only for fishing and a bit far from Thiruvanathanapuram airport in Kerala. 

UTI Mutual Fund, the country's oldest fund, has launched its unique 'UTI Wealth Builder Fund-Series II', an open ended equity oriented scheme in the Indian market.

UTI claims that UTI Wealth Builder Fund-Series II is the first of its kind in the mutual fund industry to offer asset allocation which combines traditional as well as non- traditional asset class i.e. Equity and Gold. 

Mukesh Ambani-owned Reliance Industries (RIL), the largest private oil refiner and retail giant in India has registered a 7.4 per cent growth in profit at Rs 4122 crore in the second quarter, as compared to Rs 3837 crore for the quarter ended September 30, 2007.

While company's second quarter revenue rose 39.40% to Rs 44,938 crore in the three-month period ended September 30, against Rs 32,211 crore in the year-ago period. 

Cognizant technologies, a leading provider of global consulting, technology and business process services, has entered into a five-year agreement with UK-based AstraZeneca, a leading pharmaceutical major, to provide application maintenance services in the business-critical areas of research, clinical development, and sales and marketing.

Under the extended agreement, Cognizant will work with AstraZeneca's Global Shared Services organization and implement world class, end-to-end application maintenance services.